Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
The global molecular quality controls market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 6.6% during the forecast period. Growth in this market is primarily driven by the increasing government funding for genomic projects, increasing demand for personalized medicines and declining costs of sequencing procedures, and increasing prevalence of infectious diseases, cancer, and genetic diseases. However, the additional costs involved in the quality control process and budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are the major factors that are expected to restrain the growth of this market during the forecast period.
The independent controls segment has accounted for the biggest share of the market during the forecast period
By product, the molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment accounted for the biggest share of the global molecular quality controls market in 2022. The increasing use of third-party independent quality controls is responsible for the large share of this segment.
The single-analyte controls has accounted for the biggest share of the market during the forecast period.
By analyte type, the molecular quality controls market is divided into single-analyte controls and multi-analyte controls. Single-analyte controls accounted for the biggest share of the molecular quality controls market in 2022. Factors such as the significant use of singleplex assays in hospitals, and low risk of cross-reactivity are responsible for the large share of this segment.
The infectious disease diagnostic segment accounted for the biggest share of the market in 2022
By application, the molecular quality controls market is divided into infectious disease diagnostics, genetic testing, oncology testing, and other applications (including neurology disease testing, , DNA fingerprinting, tissue typing, microbiology and cardiovascular disease testing). The infectious disease diagnostics segment accounted for the biggest share of the global molecular quality controls market in 2022. The significant increase in the prevalence of infectious diseases is responsible for the large share of this segment.
The diagnostic laboratories segment accounted for the biggest share of the market in 2022
By end users, the molecular quality controls market is segmented into academic & research institutes, diagnostic laboratories, IVD manufacturers & CROs, hospitals and other end users (home health agencies, blood banks, nursing homes, and local public health laboratories). The diagnostic laboratories segment accounted for the biggest share of the molecular quality controls market in 2022. The growing number of laboratory tests performed in diagnostic laboratories is responsible for the large share of this segment.
North America accounted for the largest share of the Molecular Quality Controls market in 2022
Based on region, the molecular quality controls market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the molecular quality controls market in 2022. The large share of this regional segment is mainly due to the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers, and easy accessibility to technologically advanced products in North America.
The break up of the profile of primary participants in the molecular Quality controls market:
The key players operating in the molecular quality controls market include Microbiologics, Inc. (US), Steck, Inc. (US), Bio-Rad Laboratories, Inc. (US), Anchor Molecular (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Microbix Biosystems Inc. (Canada), Molbio Diagnostics Pvt. Ltd. (India), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Helena Laboratories Corporation (US), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).
Research Coverage:
The report analyzes the molecular quality controls market and aims at estimating the market size and future growth potential of this market based on various segments such as product, analyte type, application, and end user. The report also includes a product portfolio matrix of various molecular quality controls products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
The independent controls segment has accounted for the biggest share of the market during the forecast period
By product, the molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment accounted for the biggest share of the global molecular quality controls market in 2022. The increasing use of third-party independent quality controls is responsible for the large share of this segment.
The single-analyte controls has accounted for the biggest share of the market during the forecast period.
By analyte type, the molecular quality controls market is divided into single-analyte controls and multi-analyte controls. Single-analyte controls accounted for the biggest share of the molecular quality controls market in 2022. Factors such as the significant use of singleplex assays in hospitals, and low risk of cross-reactivity are responsible for the large share of this segment.
The infectious disease diagnostic segment accounted for the biggest share of the market in 2022
By application, the molecular quality controls market is divided into infectious disease diagnostics, genetic testing, oncology testing, and other applications (including neurology disease testing, , DNA fingerprinting, tissue typing, microbiology and cardiovascular disease testing). The infectious disease diagnostics segment accounted for the biggest share of the global molecular quality controls market in 2022. The significant increase in the prevalence of infectious diseases is responsible for the large share of this segment.
The diagnostic laboratories segment accounted for the biggest share of the market in 2022
By end users, the molecular quality controls market is segmented into academic & research institutes, diagnostic laboratories, IVD manufacturers & CROs, hospitals and other end users (home health agencies, blood banks, nursing homes, and local public health laboratories). The diagnostic laboratories segment accounted for the biggest share of the molecular quality controls market in 2022. The growing number of laboratory tests performed in diagnostic laboratories is responsible for the large share of this segment.
North America accounted for the largest share of the Molecular Quality Controls market in 2022
Based on region, the molecular quality controls market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the molecular quality controls market in 2022. The large share of this regional segment is mainly due to the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers, and easy accessibility to technologically advanced products in North America.
The break up of the profile of primary participants in the molecular Quality controls market:
- By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
- By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
- By Region: North America - 40%, Europe – 30%, APAC –20%, Latin America – 5%,Middle East & Africa–5%
The key players operating in the molecular quality controls market include Microbiologics, Inc. (US), Steck, Inc. (US), Bio-Rad Laboratories, Inc. (US), Anchor Molecular (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Microbix Biosystems Inc. (Canada), Molbio Diagnostics Pvt. Ltd. (India), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Helena Laboratories Corporation (US), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).
Research Coverage:
The report analyzes the molecular quality controls market and aims at estimating the market size and future growth potential of this market based on various segments such as product, analyte type, application, and end user. The report also includes a product portfolio matrix of various molecular quality controls products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Analysis of key drivers (growing adoption of third-party quality controls, increasing investments in genomics, growing preference for personalized medicines, rising demand for external quality assessment support, and increasing prevalence of infectious diseases and cancer), restraints (high costs and budget constraints in clinical laboratories, and unfavorable reimbursement for molecular tests), opportunities (rising demand for multi-analyte controls, and growth opportunities in emerging countries), and challenges (changing regulatory framework)
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global molecular quality controls market
- Market Development: Comprehensive information on the lucrative emerging markets by product, analyte type, application, and end user.
- Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global molecular quality controls market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global molecular quality controls market. This report also helps stakeholders understand the pulse of the molecular quality controls market and provides them information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 STUDY LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
FIGURE 2 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS
2.2.2.2 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS
FIGURE 7 MARKET SIZE ESTIMATION: PARENT MARKET
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 MOLECULAR QUALITY CONTROLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 2 MOLECULAR QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS
2.8 MARKET LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 11 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MOLECULAR QUALITY CONTROLS MARKET
4 PREMIUM INSIGHTS
4.1 MOLECULAR QUALITY CONTROLS MARKET OVERVIEW
FIGURE 16 RISING PREVALENCE OF INFECTIOUS DISEASES AND CANCER TO DRIVE MARKET
4.2 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
FIGURE 17 INSTRUMENT-SPECIFIC CONTROLS SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.3 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION AND COUNTRY
FIGURE 18 INFECTIOUS DISEASE DIAGNOSTICS SEGMENT IN JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 MOLECULAR QUALITY CONTROLS MARKET: GEOGRAPHICAL MIX
FIGURE 19 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.5 MOLECULAR QUALITY CONTROLS MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS
FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
FIGURE 21 MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Rising number of accredited clinical laboratories
FIGURE 22 NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
5.1.1.2 Growing adoption of third-party quality controls
TABLE 3 THIRD-PARTY INDEPENDENT QUALITY CONTROLS OFFERED BY KEY COMPANIES
5.1.1.3 Increasing investments in genomics
TABLE 4 GOVERNMENT FUNDING INITIATIVES FOR GENOMICS RESEARCH (2019?2022)
5.1.1.4 Growing preference for personalized medicine
TABLE 5 US: NUMBER OF PERSONALIZED MEDICINES AVAILABLE (2008–2020)
FIGURE 23 FDA-APPROVED PERSONALIZED MEDICINES (2015–2022)
FIGURE 24 COST OF SEQUENCING PROCEDURES (2016?2021)
5.1.1.5 Increasing prevalence of infectious diseases and cancer
FIGURE 25 GLOBAL CANCER INCIDENCE, 2018–2040 (MILLION)
5.1.1.6 Rising demand for external quality assessment support
5.1.2 RESTRAINTS
5.1.2.1 Budgetary constraints in clinical laboratories
5.1.2.2 Unfavorable reimbursements for molecular tests
5.1.3 OPPORTUNITIES
5.1.3.1 Rising demand for multi-analyte controls
5.1.3.2 Growth opportunities in emerging markets
5.1.4 CHALLENGES
5.1.4.1 Stringent regulatory requirements for IVD products
5.2 INDUSTRY TRENDS
5.2.1 LYOPHILIZED/FREEZE-DRIED CONTROLS
TABLE 6 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY COMPANIES
5.3 PRICING ANALYSIS
TABLE 7 PRICE RANGE FOR MOLECULAR QUALITY CONTROLS, BY TYPE (2022)
5.4 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 27 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 28 MOLECULAR QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 MOLECULAR QUALITY CONTROLS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 TRADE ANALYSIS
5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC & LABORATORY REAGENTS
5.8.1.1 Import data for diagnostic & laboratory reagents, by country, 2018–2021 (USD million)
5.8.1.2 Export data for diagnostic & laboratory reagents, by country, 2018–2021 (USD million)
5.9 TARIFF AND REGULATORY ANALYSIS
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.2 REGULATORY ANALYSIS
5.9.2.1 North America
5.9.2.1.1 US
TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 11 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
TABLE 12 US: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
5.9.2.1.2 Canada
TABLE 13 CANADA: CLASSIFICATION OF IVD PRODUCTS
TABLE 14 CANADA: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
5.9.2.2 Europe
TABLE 15 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
5.9.2.3 Asia Pacific
5.9.2.3.1 Japan
5.9.2.3.2 China
5.9.2.3.3 India
5.10 PATENT ANALYSIS
5.10.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 29 MOLECULAR QUALITY CONTROLS MARKET: TOP PATENT OWNERS AND APPLICANTS (JANUARY 2011–JUNE 2023)
FIGURE 30 MOLECULAR QUALITY CONTROLS MARKET: TOP APPLICANT JURISDICTIONS (JANUARY 2011–JUNE 2023)
5.10.2 PATENT PUBLICATION TRENDS
FIGURE 31 MOLECULAR QUALITY CONTROLS MARKET: PATENT ANALYSIS (JANUARY 2011–FEBRUARY 2023)
TABLE 16 MOLECULAR QUALITY CONTROLS MARKET: LIST OF PATENTS/PATENT APPLICATIONS (2020–2023)
5.11 KEY CONFERENCES AND EVENTS
TABLE 17 MOLECULAR QUALITY CONTROLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS (%)
5.12.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
TABLE 19 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
5.13 TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES
FIGURE 34 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHIFT
6 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 20 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
TABLE 21 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 INDEPENDENT CONTROLS
6.2.1 MINIMIZED LOT CROSSOVERS FOR LABORATORIES AND LOW OPERATION COSTS TO DRIVE MARKET
TABLE 22 INDEPENDENT MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 23 INDEPENDENT MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENT-SPECIFIC CONTROLS
TABLE 24 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 25 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
6.3.1 POLYMERASE CHAIN REACTION
6.3.1.1 Rising applications in proteomics and genomics to propel market
TABLE 27 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR PCR, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 DNA SEQUENCING AND NGS
6.3.2.1 Increasing advancements in sequencing technologies to drive market
TABLE 28 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 OTHER TECHNOLOGIES
TABLE 29 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
7 MOLECULAR QUALITY CONTROL MARKET, BY ANALYTE TYPE
7.1 INTRODUCTION
TABLE 30 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
7.2 SINGLE-ANALYTE CONTROLS
7.2.1 RISING ADOPTION OF SINGLEPLEX ASSAYS IN HOSPITALS TO SUPPORT MARKET GROWTH
TABLE 31 SINGLE-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 32 SINGLE-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 MULTI-ANALYTE CONTROLS
7.3.1 GROWING PREFERENCE FOR COST-EFFECTIVE CONTROLS TO DRIVE MARKET
TABLE 33 MULTI-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 34 MULTI-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 35 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 INFECTIOUS DISEASE DIAGNOSTICS
8.2.1 RISING INCIDENCE OF INFLUENZA, TB, AND HIV TO DRIVE MARKET
TABLE 36 NUMBER OF COVID-19 CASES, BY COUNTRY (FEBRUARY 2023)
TABLE 37 MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 ONCOLOGY TESTING
8.3.1 GROWING FOCUS ON PERSONALIZED MEDICINE TO PROPEL MARKET
TABLE 38 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 39 MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 GENETIC TESTING
8.4.1 ABILITY TO DIAGNOSE RARE DISEASES TO SUPPORT MARKET GROWTH
TABLE 40 MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER APPLICATIONS
TABLE 41 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 MOLECULAR QUALITY CONTROLS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 42 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES TO DRIVE MARKET
TABLE 43 MOLECULAR QUALITY CONTROLS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 HOSPITALS
9.3.1 ABILITY TO CONDUCT LARGE VOLUME OF DIAGNOSTIC PROCEDURES TO PROPEL MARKET
TABLE 44 MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
9.4.1 ADVANCEMENTS IN MOLECULAR TECHNOLOGIES TO SUPPORT MARKET GROWTH
TABLE 45 MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 ACADEMIC & RESEARCH INSTITUTES
9.5.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET
TABLE 46 MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.6 OTHER END USERS
TABLE 47 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 MOLECULAR QUALITY CONTROLS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 48 MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
TABLE 49 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 53 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 Growing number of accredited clinical laboratories to drive market
FIGURE 36 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
TABLE 55 US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 56 US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 57 US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 58 US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 59 US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising funding investments for genomic research to propel market
TABLE 60 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 61 CANADA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 62 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 63 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 64 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 65 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Rising volume of diagnostic tests in clinical settings to drive market
TABLE 71 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 72 GERMANY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 73 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 74 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Growth in life sciences industry to propel market
TABLE 76 UK: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 UK: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 78 UK: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 79 UK: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 80 UK: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising prevalence of cancer and endocrine disorders to support market growth
TABLE 81 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 82 FRANCE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 83 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 84 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 85 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising incidence of age-associated chronic ailments to support market growth
TABLE 86 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 87 ITALY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 88 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 89 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 90 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing demand for prenatal and genetic testing to support market growth
TABLE 91 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 92 SPAIN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 93 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 94 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 95 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 RUSSIA
10.3.6.1 Growing acceptance of molecular diagnostics-based personalized medicine to propel market
TABLE 96 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 97 RUSSIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 98 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 99 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 100 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 101 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 REST OF EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 103 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 104 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 105 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.8 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 37 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
TABLE 106 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 110 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Established healthcare system and rising demand for high-quality IVD tests to drive market
TABLE 112 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 113 JAPAN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 114 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 115 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 116 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Rising R&D investments for advanced molecular tests to drive market
TABLE 117 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 118 CHINA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 119 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 120 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 121 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising need to secure NABL accreditations to support market growth
FIGURE 38 INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS (2012–2020)
TABLE 122 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 123 INDIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 124 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 125 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 126 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 High prevalence of infectious diseases to fuel market
TABLE 127 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 128 AUSTRALIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 129 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 130 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 132 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 133 REST OF ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 134 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 135 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.6 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
TABLE 137 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 139 LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 140 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 141 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 142 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, ‘ 2021–2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Improving healthcare infrastructure to support market growth
TABLE 143 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 144 BRAZIL: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 145 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 146 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 147 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Improving accessibility and affordability of healthcare services to support market growth
TABLE 148 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 149 MEXICO: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 150 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 151 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 152 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 153 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 154 REST OF LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 155 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 156 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 157 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 158 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 159 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 161 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 162 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS
FIGURE 39 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS OF LEADING PLAYERS
11.4 MARKET SHARE ANALYSIS
FIGURE 40 MOLECULAR QUALITY CONTROLS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
TABLE 163 MOLECULAR QUALITY CONTROLS MARKET: INTENSITY OF COMPETITIVE RIVALRY
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 41 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
11.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 42 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
11.7 COMPANY FOOTPRINT ANALYSIS
TABLE 164 MOLECULAR QUALITY CONTROLS MARKET: COMPANY FOOTPRINT ANALYSIS
TABLE 165 MOLECULAR QUALITY CONTROLS MARKET: ANALYTE TYPE FOOTPRINT ANALYSIS
TABLE 166 MOLECULAR QUALITY CONTROLS MARKET: APPLICATION FOOTPRINT ANALYSIS
TABLE 167 MOLECULAR QUALITY CONTROLS MARKET: REGIONAL FOOTPRINT ANALYSIS
TABLE 168 MOLECULAR QUALITY CONTROLS MARKET: END USER FOOTPRINT ANALYSIS
11.8 COMPETITIVE SITUATION AND TRENDS
11.8.1 PRODUCT LAUNCHES & APPROVALS
TABLE 169 PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–JUNE 2023)
11.8.2 DEALS
TABLE 170 DEALS (JANUARY 2020–JUNE 2023)
11.8.3 OTHER DEVELOPMENTS
TABLE 171 OTHER DEVELOPMENTS (JANUARY 2020–JUNE 2023)
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
12.1.1 LGC LIMITED
TABLE 172 LGC LIMITED: BUSINESS OVERVIEW
FIGURE 43 LCG LIMITED: COMPANY SNAPSHOT (2022)
12.1.2 THERMO FISHER SCIENTIFIC, INC.
TABLE 173 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 44 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
12.1.3 BIO-RAD LABORATORIES, INC.
TABLE 174 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.4 MICROBIOLOGICS, INC.
TABLE 175 MICROBIOLOGICS, INC.: BUSINESS OVERVIEW
12.1.5 ABBOTT LABORATORIES
TABLE 176 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
12.1.6 F. HOFFMANN-LA ROCHE LTD.
TABLE 177 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
12.1.7 ZEPTOMETRIX, LLC
TABLE 178 ZEPTOMETRIX, LLC: BUSINESS OVERVIEW
12.1.8 QUIDELORTHO CORPORATION
TABLE 179 QUIDELORTHO CORPORATION: BUSINESS OVERVIEW
FIGURE 48 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
12.1.9 QNOSTICS
TABLE 180 QNOSTICS: BUSINESS OVERVIEW
12.1.10 MAINE MOLECULAR QUALITY CONTROLS, INC.
TABLE 181 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
12.1.11 RANDOX LABORATORIES LTD.
TABLE 182 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
12.1.12 DANAHER CORPORATION
TABLE 183 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.13 BIO-TECHNE CORPORATION
TABLE 184 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
FIGURE 50 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2022)
12.1.14 FORTRESS DIAGNOSTICS
TABLE 185 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
12.1.15 MICROBIX BIOSYSTEMS
TABLE 186 MICROBIX BIOSYSTEMS: BUSINESS OVERVIEW
FIGURE 51 MICROBIX BIOSYSTEMS: COMPANY SNAPSHOT (2022)
12.1.16 GRIFOLS, S.A.
TABLE 187 GRIFOLS, S.A.: BUSINESS OVERVIEW
FIGURE 52 GRIFOLS, S.A.: COMPANY SNAPSHOT (2022)
12.1.17 ANCHOR MOLECULAR
TABLE 188 ANCHOR MOLECULAR: BUSINESS OVERVIEW
12.1.18 SPEEDX PTY. LTD.
TABLE 189 SPEEDX PTY. LTD.: BUSINESS OVERVIEW
12.1.19 SEEGENE INC.
TABLE 190 SEEGENE INC.: BUSINESS OVERVIEW
FIGURE 53 SEEGENE INC: COMPANY SNAPSHOT (2022)
12.1.20 HELENA LABORATORIES CORPORATION
TABLE 191 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 SERO AS
TABLE 192 SERO AS: BUSINESS OVERVIEW
12.2.2 VIRCELL, S.L.
TABLE 193 VIRCELL, S.L.: BUSINESS OVERVIEW
12.2.3 STRECK LLC
TABLE 194 STRECK LLC.: BUSINESS OVERVIEW
12.2.4 SUN DIAGNOSTICS, LLC
TABLE 195 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW
12.2.5 MOLBIO DIAGNOSTICS PVT. LTD.
TABLE 196 MOLBIO DIAGNOSTICS PVT. LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 STUDY LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
FIGURE 2 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS
2.2.2.2 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS
FIGURE 7 MARKET SIZE ESTIMATION: PARENT MARKET
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 MOLECULAR QUALITY CONTROLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 2 MOLECULAR QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS
2.8 MARKET LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 11 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MOLECULAR QUALITY CONTROLS MARKET
4 PREMIUM INSIGHTS
4.1 MOLECULAR QUALITY CONTROLS MARKET OVERVIEW
FIGURE 16 RISING PREVALENCE OF INFECTIOUS DISEASES AND CANCER TO DRIVE MARKET
4.2 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
FIGURE 17 INSTRUMENT-SPECIFIC CONTROLS SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.3 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION AND COUNTRY
FIGURE 18 INFECTIOUS DISEASE DIAGNOSTICS SEGMENT IN JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 MOLECULAR QUALITY CONTROLS MARKET: GEOGRAPHICAL MIX
FIGURE 19 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.5 MOLECULAR QUALITY CONTROLS MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS
FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
FIGURE 21 MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 Rising number of accredited clinical laboratories
FIGURE 22 NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
5.1.1.2 Growing adoption of third-party quality controls
TABLE 3 THIRD-PARTY INDEPENDENT QUALITY CONTROLS OFFERED BY KEY COMPANIES
5.1.1.3 Increasing investments in genomics
TABLE 4 GOVERNMENT FUNDING INITIATIVES FOR GENOMICS RESEARCH (2019?2022)
5.1.1.4 Growing preference for personalized medicine
TABLE 5 US: NUMBER OF PERSONALIZED MEDICINES AVAILABLE (2008–2020)
FIGURE 23 FDA-APPROVED PERSONALIZED MEDICINES (2015–2022)
FIGURE 24 COST OF SEQUENCING PROCEDURES (2016?2021)
5.1.1.5 Increasing prevalence of infectious diseases and cancer
FIGURE 25 GLOBAL CANCER INCIDENCE, 2018–2040 (MILLION)
5.1.1.6 Rising demand for external quality assessment support
5.1.2 RESTRAINTS
5.1.2.1 Budgetary constraints in clinical laboratories
5.1.2.2 Unfavorable reimbursements for molecular tests
5.1.3 OPPORTUNITIES
5.1.3.1 Rising demand for multi-analyte controls
5.1.3.2 Growth opportunities in emerging markets
5.1.4 CHALLENGES
5.1.4.1 Stringent regulatory requirements for IVD products
5.2 INDUSTRY TRENDS
5.2.1 LYOPHILIZED/FREEZE-DRIED CONTROLS
TABLE 6 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY COMPANIES
5.3 PRICING ANALYSIS
TABLE 7 PRICE RANGE FOR MOLECULAR QUALITY CONTROLS, BY TYPE (2022)
5.4 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 27 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 28 MOLECULAR QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 MOLECULAR QUALITY CONTROLS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 TRADE ANALYSIS
5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC & LABORATORY REAGENTS
5.8.1.1 Import data for diagnostic & laboratory reagents, by country, 2018–2021 (USD million)
5.8.1.2 Export data for diagnostic & laboratory reagents, by country, 2018–2021 (USD million)
5.9 TARIFF AND REGULATORY ANALYSIS
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.2 REGULATORY ANALYSIS
5.9.2.1 North America
5.9.2.1.1 US
TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 11 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
TABLE 12 US: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
5.9.2.1.2 Canada
TABLE 13 CANADA: CLASSIFICATION OF IVD PRODUCTS
TABLE 14 CANADA: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
5.9.2.2 Europe
TABLE 15 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
5.9.2.3 Asia Pacific
5.9.2.3.1 Japan
5.9.2.3.2 China
5.9.2.3.3 India
5.10 PATENT ANALYSIS
5.10.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 29 MOLECULAR QUALITY CONTROLS MARKET: TOP PATENT OWNERS AND APPLICANTS (JANUARY 2011–JUNE 2023)
FIGURE 30 MOLECULAR QUALITY CONTROLS MARKET: TOP APPLICANT JURISDICTIONS (JANUARY 2011–JUNE 2023)
5.10.2 PATENT PUBLICATION TRENDS
FIGURE 31 MOLECULAR QUALITY CONTROLS MARKET: PATENT ANALYSIS (JANUARY 2011–FEBRUARY 2023)
TABLE 16 MOLECULAR QUALITY CONTROLS MARKET: LIST OF PATENTS/PATENT APPLICATIONS (2020–2023)
5.11 KEY CONFERENCES AND EVENTS
TABLE 17 MOLECULAR QUALITY CONTROLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS (%)
5.12.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
TABLE 19 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
5.13 TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES
FIGURE 34 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHIFT
6 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 20 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
TABLE 21 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 INDEPENDENT CONTROLS
6.2.1 MINIMIZED LOT CROSSOVERS FOR LABORATORIES AND LOW OPERATION COSTS TO DRIVE MARKET
TABLE 22 INDEPENDENT MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 23 INDEPENDENT MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENT-SPECIFIC CONTROLS
TABLE 24 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 25 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
6.3.1 POLYMERASE CHAIN REACTION
6.3.1.1 Rising applications in proteomics and genomics to propel market
TABLE 27 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR PCR, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 DNA SEQUENCING AND NGS
6.3.2.1 Increasing advancements in sequencing technologies to drive market
TABLE 28 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 OTHER TECHNOLOGIES
TABLE 29 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
7 MOLECULAR QUALITY CONTROL MARKET, BY ANALYTE TYPE
7.1 INTRODUCTION
TABLE 30 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
7.2 SINGLE-ANALYTE CONTROLS
7.2.1 RISING ADOPTION OF SINGLEPLEX ASSAYS IN HOSPITALS TO SUPPORT MARKET GROWTH
TABLE 31 SINGLE-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 32 SINGLE-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 MULTI-ANALYTE CONTROLS
7.3.1 GROWING PREFERENCE FOR COST-EFFECTIVE CONTROLS TO DRIVE MARKET
TABLE 33 MULTI-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
TABLE 34 MULTI-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 35 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 INFECTIOUS DISEASE DIAGNOSTICS
8.2.1 RISING INCIDENCE OF INFLUENZA, TB, AND HIV TO DRIVE MARKET
TABLE 36 NUMBER OF COVID-19 CASES, BY COUNTRY (FEBRUARY 2023)
TABLE 37 MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 ONCOLOGY TESTING
8.3.1 GROWING FOCUS ON PERSONALIZED MEDICINE TO PROPEL MARKET
TABLE 38 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 39 MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 GENETIC TESTING
8.4.1 ABILITY TO DIAGNOSE RARE DISEASES TO SUPPORT MARKET GROWTH
TABLE 40 MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 OTHER APPLICATIONS
TABLE 41 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 MOLECULAR QUALITY CONTROLS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 42 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES TO DRIVE MARKET
TABLE 43 MOLECULAR QUALITY CONTROLS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 HOSPITALS
9.3.1 ABILITY TO CONDUCT LARGE VOLUME OF DIAGNOSTIC PROCEDURES TO PROPEL MARKET
TABLE 44 MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
9.4.1 ADVANCEMENTS IN MOLECULAR TECHNOLOGIES TO SUPPORT MARKET GROWTH
TABLE 45 MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 ACADEMIC & RESEARCH INSTITUTES
9.5.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET
TABLE 46 MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.6 OTHER END USERS
TABLE 47 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
10 MOLECULAR QUALITY CONTROLS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 48 MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
TABLE 49 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 53 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 Growing number of accredited clinical laboratories to drive market
FIGURE 36 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
TABLE 55 US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 56 US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 57 US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 58 US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 59 US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising funding investments for genomic research to propel market
TABLE 60 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 61 CANADA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 62 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 63 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 64 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 65 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Rising volume of diagnostic tests in clinical settings to drive market
TABLE 71 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 72 GERMANY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 73 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 74 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Growth in life sciences industry to propel market
TABLE 76 UK: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 UK: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 78 UK: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 79 UK: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 80 UK: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising prevalence of cancer and endocrine disorders to support market growth
TABLE 81 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 82 FRANCE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 83 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 84 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 85 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising incidence of age-associated chronic ailments to support market growth
TABLE 86 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 87 ITALY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 88 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 89 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 90 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing demand for prenatal and genetic testing to support market growth
TABLE 91 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 92 SPAIN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 93 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 94 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 95 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.6 RUSSIA
10.3.6.1 Growing acceptance of molecular diagnostics-based personalized medicine to propel market
TABLE 96 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 97 RUSSIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 98 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 99 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 100 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 101 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 REST OF EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 103 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 104 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 105 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.8 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 37 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
TABLE 106 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 110 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Established healthcare system and rising demand for high-quality IVD tests to drive market
TABLE 112 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 113 JAPAN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 114 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 115 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 116 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Rising R&D investments for advanced molecular tests to drive market
TABLE 117 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 118 CHINA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 119 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 120 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 121 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising need to secure NABL accreditations to support market growth
FIGURE 38 INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS (2012–2020)
TABLE 122 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 123 INDIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 124 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 125 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 126 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 High prevalence of infectious diseases to fuel market
TABLE 127 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 128 AUSTRALIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 129 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 130 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 132 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 133 REST OF ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 134 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 135 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.6 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
TABLE 137 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 139 LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 140 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 141 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 142 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, ‘ 2021–2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Improving healthcare infrastructure to support market growth
TABLE 143 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 144 BRAZIL: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 145 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 146 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 147 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Improving accessibility and affordability of healthcare services to support market growth
TABLE 148 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 149 MEXICO: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 150 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 151 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 152 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 153 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 154 REST OF LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 155 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 156 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 157 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 158 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 159 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)
TABLE 161 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 162 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS
FIGURE 39 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS OF LEADING PLAYERS
11.4 MARKET SHARE ANALYSIS
FIGURE 40 MOLECULAR QUALITY CONTROLS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
TABLE 163 MOLECULAR QUALITY CONTROLS MARKET: INTENSITY OF COMPETITIVE RIVALRY
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 41 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
11.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 42 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
11.7 COMPANY FOOTPRINT ANALYSIS
TABLE 164 MOLECULAR QUALITY CONTROLS MARKET: COMPANY FOOTPRINT ANALYSIS
TABLE 165 MOLECULAR QUALITY CONTROLS MARKET: ANALYTE TYPE FOOTPRINT ANALYSIS
TABLE 166 MOLECULAR QUALITY CONTROLS MARKET: APPLICATION FOOTPRINT ANALYSIS
TABLE 167 MOLECULAR QUALITY CONTROLS MARKET: REGIONAL FOOTPRINT ANALYSIS
TABLE 168 MOLECULAR QUALITY CONTROLS MARKET: END USER FOOTPRINT ANALYSIS
11.8 COMPETITIVE SITUATION AND TRENDS
11.8.1 PRODUCT LAUNCHES & APPROVALS
TABLE 169 PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–JUNE 2023)
11.8.2 DEALS
TABLE 170 DEALS (JANUARY 2020–JUNE 2023)
11.8.3 OTHER DEVELOPMENTS
TABLE 171 OTHER DEVELOPMENTS (JANUARY 2020–JUNE 2023)
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
12.1.1 LGC LIMITED
TABLE 172 LGC LIMITED: BUSINESS OVERVIEW
FIGURE 43 LCG LIMITED: COMPANY SNAPSHOT (2022)
12.1.2 THERMO FISHER SCIENTIFIC, INC.
TABLE 173 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 44 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
12.1.3 BIO-RAD LABORATORIES, INC.
TABLE 174 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.4 MICROBIOLOGICS, INC.
TABLE 175 MICROBIOLOGICS, INC.: BUSINESS OVERVIEW
12.1.5 ABBOTT LABORATORIES
TABLE 176 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
12.1.6 F. HOFFMANN-LA ROCHE LTD.
TABLE 177 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
12.1.7 ZEPTOMETRIX, LLC
TABLE 178 ZEPTOMETRIX, LLC: BUSINESS OVERVIEW
12.1.8 QUIDELORTHO CORPORATION
TABLE 179 QUIDELORTHO CORPORATION: BUSINESS OVERVIEW
FIGURE 48 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
12.1.9 QNOSTICS
TABLE 180 QNOSTICS: BUSINESS OVERVIEW
12.1.10 MAINE MOLECULAR QUALITY CONTROLS, INC.
TABLE 181 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
12.1.11 RANDOX LABORATORIES LTD.
TABLE 182 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
12.1.12 DANAHER CORPORATION
TABLE 183 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.13 BIO-TECHNE CORPORATION
TABLE 184 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
FIGURE 50 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2022)
12.1.14 FORTRESS DIAGNOSTICS
TABLE 185 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
12.1.15 MICROBIX BIOSYSTEMS
TABLE 186 MICROBIX BIOSYSTEMS: BUSINESS OVERVIEW
FIGURE 51 MICROBIX BIOSYSTEMS: COMPANY SNAPSHOT (2022)
12.1.16 GRIFOLS, S.A.
TABLE 187 GRIFOLS, S.A.: BUSINESS OVERVIEW
FIGURE 52 GRIFOLS, S.A.: COMPANY SNAPSHOT (2022)
12.1.17 ANCHOR MOLECULAR
TABLE 188 ANCHOR MOLECULAR: BUSINESS OVERVIEW
12.1.18 SPEEDX PTY. LTD.
TABLE 189 SPEEDX PTY. LTD.: BUSINESS OVERVIEW
12.1.19 SEEGENE INC.
TABLE 190 SEEGENE INC.: BUSINESS OVERVIEW
FIGURE 53 SEEGENE INC: COMPANY SNAPSHOT (2022)
12.1.20 HELENA LABORATORIES CORPORATION
TABLE 191 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 SERO AS
TABLE 192 SERO AS: BUSINESS OVERVIEW
12.2.2 VIRCELL, S.L.
TABLE 193 VIRCELL, S.L.: BUSINESS OVERVIEW
12.2.3 STRECK LLC
TABLE 194 STRECK LLC.: BUSINESS OVERVIEW
12.2.4 SUN DIAGNOSTICS, LLC
TABLE 195 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW
12.2.5 MOLBIO DIAGNOSTICS PVT. LTD.
TABLE 196 MOLBIO DIAGNOSTICS PVT. LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
